IBM has teamed up with Belgian biopharmaceutical firm UCB for a project that aims to help medical professionals use analytics technology for treating patients suffering from epilepsy.
The companies seek to develop an interactive system that converts volumes scientific and patient data into insights for doctors to use when making treatment decisions at the point of care, IBM said Thursday.
“Technologies, like analytics and cognitive computing applied to big data, are revolutionizing the way we deliver and receive care,” said Robert Merkel, IBM’s global healthcare and life sciences industry leader.
According to IBM, healthcare providers could integrate the system’s predictive analytics with clinical assessments to find the probability of success for a certain treatment approach.
This method could pave the way for cognitive computing, natural language processing and machine learning technologies for managing epilepsy, IBM says.
“IBM is dedicating innovation and expertise to help UCB prove the predictive value of this technology that would arm physicians with information that will help them identify the best possible treatment options,” Merkel added.